Faculty profile

Cynthia Hawkins

Back to faculty

ProfessorDepartment of Laboratory Medicine and PathobiologyUniversity of Toronto

Cynthia Hawkins

Professor

Department of Laboratory Medicine and Pathobiology

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Scholar ORCID

Supervision signals

Professors usually supervise graduate students in their department's programs.
123 publications in the last five years, latest in 2026.
Senior (last) author on 18 recent papers, a sign of leading a research group.
Principal investigator on 8 research grants (8 CIHR), most recently in 2022.
Supervisor on 5 trainee awards (5 CIHR), most recently in 2024.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

319

Publications

1,191

Citations

120

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Education

FRCPC in Neuropathology
MD
PhD in Physiology
BSc in Physiology

Profiles and links

University Profile Personal Website Google Scholar iDORCID

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Low Grade Glioma Pediatric Brain Tumor Single Cell Sequencing Epigenetics Brain Tumour Pediatric Aya Precision Medicine

Latest papers

Tempered optimism: Advances in the precision medicine era for pediatric low-grade glioma.
Neuro-oncology · 2026
TRAM-01: A phase 2 study of trametinib for pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas.
Neuro-oncology · 2026
CD155 regulates tumor growth and susceptibility to T cell mediated killing in diffuse midline glioma.
Neuro-oncology · 2026

All 319 publications

Latest funding

Towards immune based combinations for the treatment of IDH1 mutant replication repair deficient gliomas
CIHR · 2026 · Co-investigator
$1,275,640
Immune and Targeted Therapeutic Interception of DIPG with Enhanced Delivery Strategies
CIHR · 2025 · Co-investigator
$833,850
Elucidating Metabolic Alterations in Diffuse Midline Glioma: Towards Dietary Restriction as a Cancer Therapeutic Strategy
CIHR · 2024 · Supervisor
$120,000

All 30 grants and awards

From the 150 most recent of 319 publications.

Tempered optimism: Advances in the precision medicine era for pediatric low-grade glioma.

Kotch C, Perreault S, Power P, Adams DJ, Aldape K, Avery RA, Bandopadhayay P, Capper D, de Blank P, Entz-Werle N, Fangusaro J, Hansford JR, Hawkins C, Jacques TS, Jones DTW, Kann BH, Kranendonk MEG, Levine A, Ligon KL, Martinez-Barbera JP, Meijer L, Milde T, Mueller S, Mulcahy Levy JM, Nakano Y, Packer RJ, Pfister S, Raabe E, Robison NJ, Tabori U, Yeo KK, Vinitsky A, Zhu Y, Fisher MJ, Hargrave D, Kilburn LB

Neuro-oncology2026

DOI: 10.1093/neuonc/noag111 PMID: 42155029

TRAM-01: A phase 2 study of trametinib for pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas.

Sadat Kiaei D, Caru M, Larouche V, Clini E, Pugalenthi Saravanan D, Lippé S, Théoret Y, Décarie JC, Tabori U, Hawkins C, Ellezam B, Ospina LH, Desjardins L, Métras MÉ, Sultan S, Cantin É, Routhier MÈ, Mailloux C, Bertrand MC, Estephan K, McKeown T, Vairy S, Legault G, Renzi S, Bouffet É, Ramaswamy V, Coltin H, Lafay-Cousin L, Hukin J, Alves M, Rent T, Erker C, Jabado N, Dehaes M, Perreault S

Neuro-oncology2026

DOI: 10.1093/neuonc/noag112 PMID: 42155032

CD155 regulates tumor growth and susceptibility to T cell mediated killing in diffuse midline glioma.

Tzaridis T, Fernández EC, Eisemann T, Liou A, Andrade AF, de Biagi-Junior CAO, Hope JL, Hewson LS, McNicholas M, De Cola A, Pathania M, Becher OJ, Jabado N, Larson JD, Baker SJ, Califano A, Bagchi A, Gallitto M, Hawkins C, Filbin MG, Bradley LM, Adams PD, Pavisic J, Wechsler-Reya RJ

Neuro-oncology2026

DOI: 10.1093/neuonc/noag178 PMID: 42573567

Single-cell multi-omic analyses resolve the cellular diversity of ALK/ROS1/MET/NTRK-fused gliomas in infants and older children.

De Micheli AJ, de Biagi-Junior COA, Cascio CL, Machaalani C, Postlmayr A, Katiyar S, Maas RR, Kancherla V, Reimann R, Zápotocký M, Nobre LF, Eder SK, Rozowsky JS, Ribierre T, Zenk F, Resnick A, Clarke M, Gojo J, Tabori U, Hawkins C, Jones C, Cavalli FMG, Filbin MG, Stücklin ASG

bioRxiv : the preprint server for biology2026

DOI: 10.64898/2026.07.16.738862 PMID: 42523284

Tumor-Targeted pan-RAS Inhibition as a Novel Biologic Therapy for Diffuse Midline Glioma.

Sbergio SG, Liang H, Chen L, Canty L, Carette S, Pajovic S, Sabha N, Anguraj Vadivel AK, Beilhartz GL, Melnyk RA, Hawkins C

Neuro-oncology2026Senior author

DOI: 10.1093/neuonc/noag148 PMID: 42371788

Tumor-derived cell-free DNA detected in cerebrospinal fluid enables minimally invasive profiling of pediatric brain tumors.

Nobre L, Nakano Y, Burns I, Siddaway R, Zápotocky M, Johnson M, Rana M, Li C, Lyn RK, Yuditskiy R, Ku M, Sheth J, Levine AB, Nesvick CL, Das A, Cacciotti C, Zelcer S, Climans SA, MacDonald M, Negm L, Chung J, Bennett J, Bondoc A, Loukides J, Stengs L, Edwards M, Bouffet E, Ramaswamy V, Liu AP, Huang A, Bartels U, Dirks PB, Tabori U, Hawkins C

The Journal of clinical investigation2026Senior author

DOI: 10.1172/jci197391 PMID: 42294888

Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study.

Crowell C, Mankuzhy NP, Bennett J, Bandopadhayay P, Sturm D, Green AL, Gupta T, Chatterjee A, Epari S, Chinnaswamy G, Prasad M, Patel SH, MacNeil M, Vanan MI, Larouche V, Renzi S, Jones J, Perreault S, Mata-Mbemba D, Sangatsuda Y, Yoshimoto K, Lin E, Feddersen C, Cruz O, Pavon-Mengual M, Vizzini O, Zápotocký M, Popovacki A, Klawinski D, Hansford JR, Schlosser MP, Omene E, Alexander KL, Satgunaseelan L, Williams A, Yao K, Ronsley R, Cheng S, Ludlow L, Eisenstat D, Khuong-Quang DA, Tabouret E, André N, Matheson K, Chan A, Lim-Fat MJ, Lapointe S, Cayrol R, Coleman C, Juretic N, McThenia S, Khan S, Wright-Nadkarni M, Salloum R, Galvin RT, Sener U, Hawkins C, Imber BS, Karajannis MA, Jones DTW, Ligon KL, Jabado N, Erker C

Clinical cancer research : an official journal of the American Association for Cancer Research2026

DOI: 10.1158/1078-0432.ccr-25-3764 PMID: 41801141

"Updates on diagnostic and prognostic molecular biomarkers of CNS tumors".

Eaton S, Almotairi A, Levine A, Hawkins C

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2026Senior author

DOI: 10.1016/j.neurot.2026.e01066 PMID: 42753289

Multiclass Radiomics-Based Prediction of BRAF Mutation Status in Pediatric Low-grade Gliomas Using Multisequence MRI.

Yahav-Dovrat A, Namdar K, Wagner MW, Sheng M, Naseri M, Soldatelli MD, Dirks P, Yeom KW, Hawkins C, Eran A, Tabori U, Khalvati F, Ertl-Wagner BB

AJNR. American journal of neuroradiology2026

DOI: 10.3174/ajnr.a9296 PMID: 41819797

Ultrasound-Enhanced Drug Delivery in Pediatric Neuro-Oncology: A New Therapeutic Strategy.

Weber E, Smith CA, Hawkins C, Tabori U, Dirks PB, Rutka JT

Pharmaceutics2026

DOI: 10.3390/pharmaceutics18050576 PMID: 42198270

Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

Cynthia Hawkins

Research

Latest papers

Latest funding

Tempered optimism: Advances in the precision medicine era for pediatric low-grade glioma.

TRAM-01: A phase 2 study of trametinib for pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas.

CD155 regulates tumor growth and susceptibility to T cell mediated killing in diffuse midline glioma.

Single-cell multi-omic analyses resolve the cellular diversity of ALK/ROS1/MET/NTRK-fused gliomas in infants and older children.

Tumor-Targeted&#xa0;pan-RAS&#xa0;Inhibition&#xa0;as a Novel Biologic Therapy for&#xa0;Diffuse Midline Glioma.

Tumor-derived cell-free DNA detected in cerebrospinal fluid enables minimally invasive profiling of pediatric brain tumors.

Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study.

"Updates on diagnostic and prognostic molecular biomarkers of CNS tumors".

Multiclass Radiomics-Based Prediction of BRAF Mutation Status in Pediatric Low-grade Gliomas Using Multisequence MRI.

Ultrasound-Enhanced Drug Delivery in Pediatric Neuro-Oncology: A New Therapeutic Strategy.

Frequent collaborators

Uri Tabori

Eric Bouffet

Vijay Ramaswamy

Ute Bartels

Annie Huang

David Malkin

Nada Jabado

James Rutka

Adam Shlien

Farzad Khalvati

Gelareh Zadeh

Valérie Larouche

Michael Brudno

Sunit Das

Adam Fleming

Sebastien Perreault

Birgit Ertl-Wagner

James Drake

Nada Jabado

Birgit Ertl-Wagner

Rosanna Weksberg

Donna Johnston

Kenneth Aldape

Sheila Singh

Daria Grafodatskaya

Thomas Kislinger

Boleslaw Lach

Donald Mabbott

Ralph Dacosta

Michael Cusimano

Kjetil Ask

Kesava Reddy

Jeffrey Greenspoon

Kevin Charles Jones

Olufemi Ajani

Hong Han

Sunjay Sharma

Geoffrey Liu

Tumor-Targeted pan-RAS Inhibition as a Novel Biologic Therapy for Diffuse Midline Glioma.